Compare Ventas, Inc. (VTR) vs Healthpeak Properties, Inc. (DOC) Stock

Ventas, Inc. (VTR) offers the better valuation at 159.6x trailing P/E (114.3x forward), making it the more compelling value choice. Analysts rate Ventas, Inc. (VTR) a "Buy" — based on 32 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Ventas, Inc. (VTR) is the cheapest at 159.6x versus Healthpeak Properties, Inc. at 176.8x. On forward P/E, Healthpeak Properties, Inc. is actually cheaper at 66.6x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Ventas, Inc. (VTR) delivered a total return of +80.6%, compared to -10.9% for Healthpeak Properties, Inc. (DOC). A $10,000 investment in VTR five years ago would be worth approximately $18K today (assuming dividends reinvested). Over 10 years, the gap is even starker: VTR returned +97.3% versus DOC's +30.4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Ventas, Inc. (VTR) is the lower-risk stock at 0.23β versus Healthpeak Properties, Inc.'s 0.48β — meaning DOC is approximately 111% more volatile than VTR relative to the S&P 500. On balance sheet safety, Ventas, Inc. (VTR) carries a lower debt/equity ratio of 104% versus 126% for Healthpeak Properties, Inc. — giving it more financial flexibility in a downturn.

Ventas, Inc. (VTR) is the more profitable company, earning 4.3% net margin versus 2.5% for Healthpeak Properties, Inc. — meaning it keeps 4.3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DOC leads at 19.3% versus 14.2% for VTR. At the gross margin level — before operating expenses — DOC leads at 22.5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Healthpeak Properties, Inc. (DOC) trades at 66.6x forward P/E versus 114.3x for Ventas, Inc. — 47.7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DOC: 3.7% to $18.33.

In this comparison, DOC (6.9% yield) pays a dividend. VTR does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Healthpeak Properties, Inc. (DOC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.48), 6.9% yield). Both have compounded well over 10 years (DOC: +30.4%, VTR: +97.3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: VTR is a mid-cap quality compounder stock; DOC is a mid-cap income-oriented stock. DOC pays a dividend while VTR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.